The review found no eligible studies for this question.
The review found no eligible studies for this question.
Citrate probably leads to lower major bleeding compared with unfractionated heparin (moderate certainty).
Citrate showed no clear difference in death at 28 days compared with unfractionated heparin (moderate certainty).
Citrate probably leads to higher successful prevention of clotting compared with unfractionated heparin (moderate certainty).
Citrate showed no clear difference in treatment cessation due to adverse events compared with unfractionated heparin (low certainty).
Citrate showed no clear difference in recovery of kidney function compared with unfractionated heparin (low certainty).
Citrate showed no clear difference in thrombocytopenia compared with unfractionated heparin (low certainty).
The review found no eligible studies for this question.